Testing RG1-VLP Vaccine to Prevent HPV-related Cancers

Condition:   Human Papillomavirus-Related Carcinoma Interventions:   Procedure: Biospecimen Collection;   Biological: HPV16 RG1 VLP Vaccine;   Other: Questionnaire Administration;   Biological: Recombinant Human Papillomavirus Nonavalent Vaccine;   Other: Saline Sponsor:   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials